Murphy Capital Management’s Arena Pharmaceuticals Inc ARNA Stock Holding History

Murphy Capital Management’s Portfolio ARNA Stock Details ARNA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q3	–	Sell	-2,300	Closed	-$106K	–	326
2015 Q2	$106K	Sell	2,300 -2,350	-51%	-$102K	0.02%	308
2015 Q1	$203K	Hold	4,650	–	–	0.03%	312
2014 Q4	$161K	Buy	4,650 +200	+4%	+$8.12K	0.02%	320
2014 Q3	$186K	Sell	4,450 -50	-1%	-$2.23K	0.03%	320
2014 Q2	$263K	Hold	4,500	–	–	0.04%	287
2014 Q1	$283K	Hold	4,500	–	–	0.05%	279
2013 Q4	$263K	Hold	4,500	–	–	0.05%	269
2013 Q3	$237K	Hold	4,500	–	–	0.04%	275
2013 Q2	$346K	Buy	+4,500	New	+$367K	0.07%	221

Other funds holding ARNA

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

CCM

Camber Capital Management Boston, Massachusetts $1.07B AUM 8.19% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return

Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Murphy Capital Management's ARNA Position: Q3 2015 in Review

Murphy Capital Management sold out of Arena Pharmaceuticals Inc (ARNA) in Q3 2015, closing a stake of 2,300 shares — an estimated $106K sold.

Murphy Capital Management first reported a position in ARNA in Q2 2013 and held it in 9 quarters. The position peaked at $346K in Q2 2013. 120 funds tracked by Wall St. Rank hold ARNA as of Q3 2015.

Murphy Capital Management reported no remaining Arena Pharmaceuticals Inc position as of Q3 2015 after selling out during the quarter.
Murphy Capital Management sold 2,300 Arena Pharmaceuticals Inc shares in Q3 2015, an estimated $106K.
Murphy Capital Management first reported a position in Arena Pharmaceuticals Inc in Q2 2013 and held it in 9 quarters.
Murphy Capital Management's Arena Pharmaceuticals Inc position peaked at $346K in Q2 2013.
120 funds tracked by Wall St. Rank held Arena Pharmaceuticals Inc as of Q3 2015.

Based on Murphy Capital Management's 13F filing for Q3 2015, filed 14 Oct 2015.